Main Sequence Ventures
Main Sequence Ventures is an Australian deep-tech venture capital firm founded by CSIRO in 2017 that invests from seed to Series B in companies connected to science and research commercialisation.
- Investor type
- Venture capital
- Quantum focus
- Deep-tech investor
- Headquarters
- Australia
- Founded
- 2017
- Assets under management
- The firm states it has over $1 billion under management.
- Website
- mseq.vc
Main Sequence Ventures describes itself as a venture capital firm focused on deep technology. According to its website, it backs founders using scientific expertise to address large industrial and societal challenges, and invests from seed to Series B. The firm says it was founded by CSIRO in 2017 to help bridge the commercialisation gap for Australian research spinouts, startups and SMEs linked to publicly funded R&D.
The firm states that its co-founder is CSIRO, Australia's science agency, and that it has more than $1 billion under management. Its site says Fund 1 was a $240 million CSIRO Innovation Fund, Fund 2 was $310 million, and Fund 3 raised $450 million. The published challenge areas include "Enable the next intelligence leap" alongside climate, health, food, space and industrial productivity themes.
Sources
Facts on this page come from the sources below, retrieved by DesignQuantum.
Last verified: October 28, 2026